Sort by
Refine Your Search
-
Listed
-
Category
-
Country
- United States
- Netherlands
- Spain
- Germany
- France
- United Kingdom
- Sweden
- Poland
- Italy
- Portugal
- Canada
- Australia
- Norway
- Singapore
- Belgium
- Czech
- Switzerland
- Austria
- Ireland
- Finland
- Denmark
- United Arab Emirates
- Japan
- Luxembourg
- Latvia
- Hong Kong
- China
- Brazil
- Croatia
- Greece
- Romania
- Estonia
- Mexico
- South Africa
- Worldwide
- Bulgaria
- Hungary
- New Zealand
- Slovakia
- Slovenia
- Cyprus
- Europe
- Iceland
- India
- Macau
- Malta
- Taiwan
- Vietnam
- 38 more »
- « less
-
Program
-
Field
- Medical Sciences
- Biology
- Economics
- Computer Science
- Business
- Engineering
- Science
- Mathematics
- Chemistry
- Education
- Psychology
- Materials Science
- Social Sciences
- Arts and Literature
- Law
- Humanities
- Sports and Recreation
- Environment
- Earth Sciences
- Linguistics
- Philosophy
- Electrical Engineering
- Design
- Physics
- Statistics
- 15 more »
- « less
-
Welcome to Maastricht University! We have developed a new class of oncology drugs that exploit the tumour microenvironment for selective activation that target the NOTCH stem-cell pathway in cancer
-
/ . His/her work will also be part of a close collaboration with the Evolutionary Cell Biology laboratory at the Centre for Organismal Studies, University of Heidelberg, Germany (https://www.cos.uni
-
Oncology, Cancer & Blood Diseases Institute - Cell & Immune Therapy – Physician-Scientist - JR214185
Diseases Institute integrates research and clinical programs in cancer biology, hematology, oncology, gene and cell therapy, and related disciplines to translate fundamental discoveries into improved
-
Frequency of calls: 12 International mobility required: no Website for additional job details https://web.uniroma1.it/trasparenza/bando/246817_apidrdsa2026003 Work Location(s) Number of offers
-
Starting Date 1 Dec 2026 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer
-
, including a living and mobility allowance. This amount corresponds to the contractual gross salary and is indicated before deduction of employer costs, employee taxes and social security contributions
-
, including a living and mobility allowance. This amount corresponds to the contractual gross salary and is indicated before deduction of employer costs, employee taxes and social security contributions
-
, including a living and mobility allowance. This amount corresponds to the contractual gross salary and is indicated before deduction of employer costs, employee taxes and social security contributions
-
expertise in cell and molecular biology, assay development, and therapeutic screening. The successful candidate will be responsible for driving ASO therapeutic development projects, including candidate design
-
Oct 2026 - 23:00 (Europe/Oslo) Country Norway Type of Contract Temporary Job Status Full-time Hours Per Week 37.5 Is the job funded through the EU Research Framework Programme? Not funded by a EU